Subscribe to our Newsletters !!
Drug quality is defined not only how a drug is man
Eppendorf is launching the new VisioNize® box 2,
The journey and merging of sperm and egg cells is
This year, the Hamburg based life sciences company
Alembic Pharmaceutica
Since it’s an ingredient in so many foods, you h
In a world constantly in motion, Microbioz India r
Italy said on Saturday it aimed to vaccinate at least 80 percent of its population at the end of September, after criticism about the slow pace of the rollout of a coronavirus vaccination campaign in one of worst-hit countries in Europe.
Francesco Paolo Figliuolo, a military general and new special commissioner for coronavirus, published a national plan to administer 500,000 doses per day at full capacity, according to a cabinet office record.
Italy has enrolled 101,881 deaths since the outbreak emerged in the nation in February 2020, the second-highest toll in Europe after Britain and the seventh-highest on the planet. It’s reported 3.2 million cases of disease to date.
Some 1.95 million Italians, equivalent to just 3.8% of the eligible population, have been administered two jabs of vaccine so far, sparking public criticism about the slow pace of the rollout and prompting the appointment of Figliuolo.
Italy expects to get a growing number of vaccines, with complete deliveries increasing from 15.7 million doses in the first quarter to 52.5 million between April and June to a summit of 84.9 million in the third quarter, the document said.
It plans to broaden the health operators administering shots by fostering an existing agreement to employ family doctors and by utilizing dentists, junior doctors, doctors from the Italian Sports Medicine Federation and others.
Along with healthcare facilities in operation as vaccination points, Italy will use military barracks, manufacturing sites, large-scale retail outlets, gyms, schools and Catholic church’s facilities.
Only under 51 million Italians are eligible for the vaccine and 60% of them could be vaccinated by the end of July, reaching the first threshold for herd immunity, the record showed.
Patheon Thermo Fischer, part of U.S.-listed Thermo Fischer Scientific, is ready to launch mass production of a COVID-19 vaccine in Italy, a government source said on Friday.
